• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Weekly injections shows HIV-1 viral suppression europeanpharmaceuticalreview
    June 11, 2018
    Results from a pivotal trial of a new HIV therapy, show that PRO 140 is an effective, long-acting therapeutic for previously treated HIV-1 infected patients…
  • Gilead reports positive mid-stage data for HIV therapy bictegravir firstwordpharma
    February 15, 2017
    Gilead Sciences announced results from a Phase II study demonstrating that the experimental integrase strand transfer inhibitor bictegravir achieved high virologic response rates similar to ViiV Healthcare's integrase inhibitor Tivicay (dolutegravir) in t

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service